175 related articles for article (PubMed ID: 26420879)
21. Kinetics of endoglycoceramidase action toward cell-surface glycosphingolipids of erythrocytes.
Ito M; Ikegami Y; Yamagata T
Eur J Biochem; 1993 Dec; 218(2):645-9. PubMed ID: 8269955
[TBL] [Abstract][Full Text] [Related]
22. Characterization of Glycosphingolipids and Their Diverse Lipid Forms through Two-Stage Matching of LC-MS/MS Spectra.
Bailey LS; Huang F; Gao T; Zhao J; Basso KB; Guo Z
Anal Chem; 2021 Feb; 93(6):3154-3162. PubMed ID: 33534538
[TBL] [Abstract][Full Text] [Related]
23. Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).
Sandhoff R; Sandhoff K
Adv Neurobiol; 2023; 29():333-390. PubMed ID: 36255681
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Residual Human-Induced Pluripotent Stem Cells in Human Chondrocytes by Cell Type-Specific Glycosphingolipid Glycome Analysis Based on the Aminolysis-SALSA Technique.
Miyazaki T; Hanamatsu H; Xu L; Onodera T; Furukawa JI; Homan K; Baba R; Kawasaki T; Iwasaki N
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905707
[TBL] [Abstract][Full Text] [Related]
25. Glycosphingolipid expression in human skeletal and heart muscle assessed by immunostaining thin-layer chromatography.
Müthing J; Cacić M
Glycoconj J; 1997 Jan; 14(1):19-28. PubMed ID: 9076510
[TBL] [Abstract][Full Text] [Related]
26. Specific hydrolysis of intact erythrocyte cell-surface glycosphingolipids by endoglycoceramidase. Lack of modulation of erythrocyte glucose transporter by endogenous glycosphingolipids.
Ito M; Ikegami Y; Tai T; Yamagata T
Eur J Biochem; 1993 Dec; 218(2):637-43. PubMed ID: 8269954
[TBL] [Abstract][Full Text] [Related]
27. Verification and refinement of cellular glycosphingolipid profiles using HPLC.
Vieira DB; Thur K; Sultana S; Priestman D; van der Spoel AC
Biochem Cell Biol; 2015 Dec; 93(6):581-6. PubMed ID: 26393781
[TBL] [Abstract][Full Text] [Related]
28. Structural profiling of individual glycosphingolipids in a single thin-layer chromatogram by multiple sequential immunodetection matched with Direct IR-MALDI-o-TOF mass spectrometry.
Souady J; Soltwisch J; Dreisewerd K; Haier J; Peter-Katalinić J; Müthing J
Anal Chem; 2009 Nov; 81(22):9481-92. PubMed ID: 19908908
[TBL] [Abstract][Full Text] [Related]
29. Analysis of neutral glycosphingolipids from Trypanosoma brucei.
Uemura A; Watarai S; Kushi Y; Kasama T; Ohnishi Y; Kodama H
Vet Parasitol; 2006 Sep; 140(3-4):264-72. PubMed ID: 16806714
[TBL] [Abstract][Full Text] [Related]
30. High-performance thin-layer chromatography/mass spectrometry for rapid analysis of neutral glycosphingolipids.
Miyazaki M; Yonesige A; Matsuda J; Kuroda Y; Kojima N; Suzuki A
J AOAC Int; 2008; 91(5):1218-26. PubMed ID: 18980144
[TBL] [Abstract][Full Text] [Related]
31. Shotgun glycomics: a microarray strategy for functional glycomics.
Song X; Lasanajak Y; Xia B; Heimburg-Molinaro J; Rhea JM; Ju H; Zhao C; Molinaro RJ; Cummings RD; Smith DF
Nat Methods; 2011 Jan; 8(1):85-90. PubMed ID: 21131969
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of glycosphingolipid glycans by lectin microarrays and MALDI-TOF mass spectrometry.
Du H; Yu H; Yang F; Li Z
Nat Protoc; 2021 Jul; 16(7):3470-3491. PubMed ID: 34099941
[TBL] [Abstract][Full Text] [Related]
33. Software utilities for the interpretation of mass spectrometric data of glycoconjugates: application to glycosphingolipids of human serum.
Souady J; Dadimov D; Kirsch S; Bindila L; Peter-Katalinić J; Vakhrushev SY
Rapid Commun Mass Spectrom; 2010 Apr; 24(7):1039-48. PubMed ID: 20213680
[TBL] [Abstract][Full Text] [Related]
34. Quantitative characterization of tissue globotetraosylceramides in a rat model of polycystic kidney disease by PrimaDrop sample preparation and indirect high-performance thin layer chromatography-matrix-assisted laser desorption/ionization-time-of-flight-mass spectrometry with automated data acquisition.
Ruh H; Sandhoff R; Meyer B; Gretz N; Hopf C
Anal Chem; 2013 Jul; 85(13):6233-40. PubMed ID: 23701631
[TBL] [Abstract][Full Text] [Related]
35. Glycosphingolipid-Glycan Signatures of Acute Myeloid Leukemia Cell Lines Reflect Hematopoietic Differentiation.
Wang D; Zhang T; Madunić K; de Waard AA; Blöchl C; Mayboroda OA; Griffioen M; Spaapen RM; Huber CG; Lageveen-Kammeijer GSM; Wuhrer M
J Proteome Res; 2022 Apr; 21(4):1029-1040. PubMed ID: 35168327
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive characterization of complex glycosphingolipids in human pancreatic cancer tissues.
Hořejší K; Jin C; Vaňková Z; Jirásko R; Strouhal O; Melichar B; Teneberg S; Holčapek M
J Biol Chem; 2023 Mar; 299(3):102923. PubMed ID: 36681125
[TBL] [Abstract][Full Text] [Related]
37. High-sensitivity quantification of glycosphingolipid glycans by ESI-MS utilizing ozonolysis-based release and isotopic Girard's reagent labeling.
Wang C; Wen Y; Yang M; Huang L; Wang Z; Fan J
Anal Biochem; 2019 Oct; 582():113355. PubMed ID: 31276651
[TBL] [Abstract][Full Text] [Related]
38. Glycosphingolipid dynamics in human embryonic stem cell and cancer: their characterization and biomedical implications.
Ho MY; Yu AL; Yu J
Glycoconj J; 2017 Dec; 34(6):765-777. PubMed ID: 27549315
[TBL] [Abstract][Full Text] [Related]
39. Combining Glucose Units,
Wongtrakul-Kish K; Walsh I; Sim LC; Mak A; Liau B; Ding V; Hayati N; Wang H; Choo A; Rudd PM; Nguyen-Khuong T
Anal Chem; 2019 Jul; 91(14):9078-9085. PubMed ID: 31179689
[TBL] [Abstract][Full Text] [Related]
40. Antibodies against platelet glycosphingolipids: detection in serum by quantitative HPTLC-autoradiography and association with autoimmune and alloimmune processes.
Koerner TA; Weinfeld HM; Bullard LS; Williams LC
Blood; 1989 Jul; 74(1):274-84. PubMed ID: 2752115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
